Hypercalcemia-Induced Hypokalemic Metabolic Alkalosis in a Multiple Myeloma Patient: The Risk of Furosemide Use

Publisher： Karger

E-ISSN： 1662-6575|8|3|389-393

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.8, Iss.3, 2015-09, pp. : 389-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic Alkalosis in the Critically III

By Webster Nigel R.   Kulkarni Vivek  

Critical Reviews in Clinical Laboratory Sciences, Vol. 36, Iss. 5, 1999-10 ,pp. : 497-510

Informa Healthcare

Access to resources Recommend Favorite

Bortezomib-Induced Rhabdomyolysis in Multiple Myeloma

By  

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 203-206

Karger

Access to resources Recommend Favorite

Use of Erythropoietin in Patients with Multiple Myeloma

By  

Oncology Research and Treatment, Vol. 26, Iss. 1, 2003-03 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Ibandronate for the Treatment of Hypercalcemia or Nephrocalcinosis in Patients with Multiple Myeloma and Acute Renal Failure: Case Reports

By  

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 165-172

Karger

Access to resources Recommend Favorite

Bacteroides fragilis Pyomyositis in a Patient with Multiple Myeloma

By  

THE JOURNAL OF DERMATOLOGY, Vol. 23, Iss. 2, 1996-02 ,pp. : 129-132

John Wiley & Sons Inc

Access to resources Recommend Favorite